InsidersTradesSigma
Follow the 广生堂 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 广生堂 has published 3 public disclosures. Market capitalisation: €13.7bn. The latest transaction was disclosed on 17 March 2022 (Purchase). Among the most active insiders: 李国平. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
广生堂是一家在 XSHE 市场上市的健康和制药公司。它专注于药品和保健品的开发和生产。